This week on the pod, we’re thrilled to be joined by Adam Terry, CEO and co-founder of Cantrip and On the Brightside—and absolute WEALTH of knowledge on all things THC regulation and functional beverages.
Adam walks us through his journey in the cannabis beverage industry and pivot into a new kind of functional drink. He explains why the low-dose THC hypothesis didn’t pan out, the science behind the new functional ingredient he’s betting on, and the tricky retail landscape of functional beverages.
This is a great follow-up episode to our interview with Jake Bullock, CEO and co-founder of Cann—offering some updates and rare insights into the ever-changing THC regulatory environment!
The breakdown
0:00 - Intro and Adam Terry’s background
1:56 - The low-dose THC hypothesis
6:13 - The hemp ban and birth of On the Brightside
7:14 - What is kanna?
9:09 - Educating consumers on an unknown ingredient
13:20 - Retail strategy: soda, function & shelf placement
19:55 - Kanna vs. other functional ingredients
24:01 - The science: why kanna is more pro-social than THC
27:50 - Rethinking the functional beverage category
37:22 - The future of Cantrip & hemp ban outlook
🎧 Love the show? Subscribe to the Express Checkout podcast wherever you get your podcasts! New episodes drop weekly.
📧 Get the inside scoop Subscribe to Express Checkout, our newsletter packed with consumer insights, trends, and exclusive content straight to your inbox at expresscheckout.co.
🗣️ Let’s connect! Follow us for behind-the-scenes content, quick tips, and more: @expresscheckout
💬 Join the conversation Have a product you’re curious about? DM us your questions or drop them in the comments—your topic could be featured in our next episode! If you have any thoughts/questions/suggestions, feel free to email us at hello@expresscheckout.co :)
⭐ Help us grow If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify. It helps other curious consumers find us!
